Guardant Health’s Shield colorectal test covered in Carelon guidelines from Nov. 15
Guardant Health said its Shield™ blood test for colorectal cancer screening will be covered in Carelon Healthcare Services clinical guidelines effective November 15.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) will be covered in Carelon Healthcare Services clinical guidelines effective November 15.
Carelon Healthcare Services is one of the largest specialt…